Phenotypic clustering of heart failure with preserved ejection fraction reveals different rates of hospitalization

被引:19
作者
Casebeer, Adrianne [1 ]
Horter, Libby [1 ]
Hayden, Jennifer [1 ]
Simmons, Jeff [2 ]
Evers, Thomas [3 ]
机构
[1] Humana Healthcare Res Inc, Louisville, KY USA
[2] Humana Inc, Healthcare Serv, Louisville, KY USA
[3] Bayer AG, Digital & Commercial Innovat, Wuppertal, Germany
关键词
healthcare utilization; heart failure; hospitalization; preserved ejection fraction; COMORBIDITY INDEX; EPIDEMIOLOGY; PREVALENCE;
D O I
10.2459/JCM.0000000000001116
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Approximately 50% of patients with heart failure have preserved (>= 50%) ejection fraction (HFpEF). Improved understanding of the phenotypic heterogeneity of HFpEF might facilitate development of targeted therapies and interventions. Methods This retrospective study characterized a cohort of patients with HFpEF based on similar clinical profiles and evaluated 1-year heart failure related hospitalization. Enrolment, medical and pharmacy data were used to identify patients newly diagnosed with heart failure enrolled in a Medicare Advantage Prescription Drug or commercial healthcare plan. To identify only those patients with HFpEF, we used natural language processing techniques of ejection fraction values abstracted from a linked free-text clinical notes data source. The study population comprised 1515 patients newly identified with HFpEF between 1 January 2011 and 31 December 2015. Results Using unsupervised machine learning, we identified three distinguishable patient clusters representing different phenotypes: cluster-1 patients had the lowest prevalence of heart failure comorbidities and highest mean age; cluster-2 patients had higher prevalence of metabolic syndrome and pulmonary disease, despite younger mean age; and cluster-3 patients had higher prevalence of cardiac arrhythmia and renal disease. Cluster-3 had the highest 1-year heart failure related hospitalization rates. Within-cluster analysis, prior use of diuretics (cluster-1 and cluster-2) and age (cluster-2 and cluster-3) was associated with 1-year heart failure related hospitalization. Combination therapy was associated with decreased 1-year heart failure related hospitalization in cluster-1. Conclusion This study demonstrated that clustering can be used to characterize subgroups of patients with newly identified HFpEF, assess differences in heart failure related hospitalization rates at 1 year and suggest patient subtypes may respond differently to treatments or interventions.
引用
收藏
页码:45 / 52
页数:8
相关论文
共 15 条
[1]   Machine Learning Methods Improve Prognostication, Identify Clinically Distinct Phenotypes, and Detect Heterogeneity in Response to Therapy in a Large Cohort of Heart Failure Patients [J].
Ahmad, Tariq ;
Lund, Lars H. ;
Rao, Pooja ;
Ghosh, Rohit ;
Warier, Prashant ;
Vaccaro, Benjamin ;
Dahlstrom, Ulf ;
O'Connor, Christopher M. ;
Felker, G. Michael ;
Desai, Nihar R. .
JOURNAL OF THE AMERICAN HEART ASSOCIATION, 2018, 7 (08)
[2]   Epidemiology of Heart Failure with Preserved Ejection Fraction [J].
Andersson, Charlotte ;
Vasan, Ramachandran S. .
HEART FAILURE CLINICS, 2014, 10 (03) :377-+
[3]   ADAPTING A CLINICAL COMORBIDITY INDEX FOR USE WITH ICD-9-CM ADMINISTRATIVE DATABASES [J].
DEYO, RA ;
CHERKIN, DC ;
CIOL, MA .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1992, 45 (06) :613-619
[4]   Heart failure with preserved left ventricular Systolic function - Epidemiology clinical characteristics and prognosis [J].
Hogg, K ;
Swedberg, K ;
McMurray, J .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2004, 43 (03) :317-327
[5]  
Iorio A, 2018, EUR J HEART FAIL, V20, P1257, DOI 10.1002/ejhf.1202
[6]  
Johnson AE, 2017, CIRCULATION, V136
[7]   Characterization of subgroups of heart failure patients with preserved ejection fraction with possible implications for prognosis and treatment response [J].
Kao, David P. ;
Lewsey, James D. ;
Anand, Inder S. ;
Massie, Barry M. ;
Zile, Michael R. ;
Carson, Peter E. ;
McKelvie, Robert S. ;
Komajda, Michel ;
McMurray, John J. V. ;
Lindenfeld, JoAnn .
EUROPEAN JOURNAL OF HEART FAILURE, 2015, 17 (09) :925-935
[8]   Development of a comorbidity index using physician claims data [J].
Klabunde, CN ;
Potosky, AL ;
Legler, JM ;
Warren, JL .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2000, 53 (12) :1258-1267
[9]   Noncardiac Comorbidities in Heart Failure With Reduced Versus Preserved Ejection Fraction [J].
Mentz, Robert J. ;
Kelly, Jacob P. ;
von Lueder, Thomas G. ;
Voors, Adriaan A. ;
Lam, Carolyn S. P. ;
Cowie, Martin R. ;
Kjeldsen, Keld ;
Jankowska, Ewa A. ;
Atar, Dan ;
Butler, Javed ;
Fiuzat, Mona ;
Zannad, Faiez ;
Pitt, Bertram ;
O'Connor, Christopher M. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (21) :2281-2293
[10]   Trends in prevalence and outcome of heart failure with preserved ejection fraction [J].
Owan, Theophilus E. ;
Hodge, David O. ;
Herges, Regina M. ;
Jacobsen, Steven J. ;
Roger, Veronique L. ;
Redfield, Margaret M. .
NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (03) :251-259